Search - tctmd.com

Displaying 1 - 20 of 104

Sort: Relevancy | Date

News Industry News

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

November 29, 2016

News Conference News AHA 2016

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

Yael L. Maxwell

November 16, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

News Daily News

Medication Compliance May Impact Revascularization Outcomes

L.A. McKeown

October 25, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Industry News

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

September 15, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Opinion Editor's Corner

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

Shelley Wood

August 24, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Industry News

Spectranetics Receives CE Mark for AngioSculptX™

August 11, 2016

News Industry News

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

July 07, 2016

News Industry News

Arizona patient will receive first U.S.-approved fully dissolving heart stent

July 06, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Industry News

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

June 28, 2016

News Industry News

SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon

April 06, 2016

News Industry News

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

March 21, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

Advertisement

Micell Technologies Announces First Patient Enrolled In Landmark Registration Trial of MiStent In Japan

PCI at Centers Without Surgical Backup ‘Probably OK,’ Nationwide Data Suggests

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Medication Compliance May Impact Revascularization Outcomes

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Veryan Medical announces that the first patient has been enrolled into the Company sponsored MIMICS-3D Registry by Michael Lichtenberg MD of Arnsberg, Germany

TCTMD’s Top 10 Most Popular Stories for August 2016

ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness

The Bioresorbable Stent Story So Far: What Promise? What Price?

Spectranetics Receives CE Mark for AngioSculptX™

QT Vascular Receives CE Mark Clearance For Chocolate Heart™, A Novel Drug-Coated Coronary Balloon

Arizona patient will receive first U.S.-approved fully dissolving heart stent

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

QT Vascular Receives FDA 510(k) Clearance For Chocolate XD™, A Novel PTCA Balloon

SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon

NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content